Fifth disease - Chechishanu Chirwere
☆ Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
16-month-year-old with Chechishanu Chirwere (Fifth disease) ― Matama ose ari maviri anotsvuka, kuita searohwa nembama, uye tumapundu maculopapular kubuda pamuviri.
Erythema pamatama ose.
References
Fifth disease , inozivikanwawo se erythema infectiosum, chirwere chehutachiwana chinokonzerwa nemunhu parvovirus B19. Inonyanya kuwanda muvana, kazhinji inobata avo vari pakati pemakore mana kusvika gumi nemana. Zviratidzo zvinowanzotanga nefivha isinganyanyi, kutemwa nemusoro, kuvaviwa nehuro, uye kunzwa sefuruu. Vana vanogona kukudziridza ruvara rutsvuku rwakasiyana pachiso chakafanana ne slapped cheeks , pamwe chete nemararamiro akaenzana pamuviri, maoko, nemakumbo. Muvanhu vakuru, kurwadziwa kwemajoini kunowanzoitika, izvo zvinogona kuonekwa mavhiki mushure mekutanga kwehutachiona. Zvinonzwisisika, vanenge 20 kusvika 30% yevakuru vane utachiona hweparvovirus B19 vanogona kusaratidza chero zviratidzo.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Ngozi yekupfuudza parvovirus B19 kubva kuna amai kuenda kumwana inosvika zvikamu makumi matatu nezvitatu kubva muzana, uye chikamu chetatu kubva muzana chevakadzi vane hutachiwana vari kusangana nematambudziko muvacheche vavo. Kana amai vabatwa nechirwere ichi mavhiki makumi maviri enhumbu asati asvika, mikana yematambudziko akaita sedambudziko reropa nekuwanda kwemvura mumuviri wemwana inowedzera. Kutanga kubata chirwere ichi, tinofanira kutarisa kana murwere akambosangana neparvovirus nekuongororwa kune mamwe masoja ekudzivirira chirwere (IgM) . Kana bvunzo yacho isingaratidzi kuburitswa asi ichiratidza hutachiona huchangobva kuitika, murwere anoda kutariswa zvakanyanya panguva yekuzvitakura, kusanganisira nguva dzose ma ultrasound scans kuti atarise dzimwe nyaya dzehutano hwemwana.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
chechishanu chirwere (fifth disease) inotanga nefivha yakaderera, kutemwa nemusoro, mapundu, uye zviratidzo zvakaita sedzihwa, semhuno inomhanya kana kuzara. Zviratidzo izvi zvinopfuura, zvino mazuva mashomanana gare gare, kuputika kunoratidzika. Ruvara rutsvuku rwakatsvuka runowanzoonekwa pachiso, kunyanya pamatama. (saka zita rekuti "chirwere chedama chembama"). Pamusoro pematama matsvuku, vana vanowanzoita tumapundu dzvuku, dzvuku pamuviri wese, maoko epamusoro, torso, uye makumbo zviri izvo zvinowanzoitika.
Chirwere chacho chinowanzova chinyoro, asi mumadzimai ane pamuviri, hutachiona mukutanga kwetatu kwave kwakabatanidzwa kune hydrops fetalis, zvichiita kuti pave nekuparara kwepamuviri.
○ Kurapwa
Hapana kurapa kwakananga kunodiwa sezvo kunowanzovandudza nekufamba kwenguva.